CCI Photonics Ltd
Aims
CCI Photonics specialise in the making medical instruments and supplies, as well as conducting biotechnology research and development.
Overview
CCI Photonics was established in July of 2023 and specialises in the innovation of medical instruments and supplies, in addition to biotechnology research and development. A spinout from an interdisciplinary translational research project undertaken in collaboration with Lancaster University and University Hospitals of Morecambe Bay NHS Foundation Trust, CCI Photonics utilises AI to quickly identify microbes from small samples.
Results and Outcomes
Tab Content: For Partners and Engagement
The company was shortlisted in 2024 from over 200 Northern start-ups in a wide variety of sectors to take part in the PraeSeed programme from capital firm Praetura Ventures. The scheme provides sessions from innovation experts and the opportunity to receive an equity investment of £200,000.
Tab Content: For Academics
Identifying a need for the faster detection of AMR (Antimicrobial Resistant) infections to prevent deaths, which have seen an increase of 2.2% since 2021, CCI Photonics have developed a portable diagnostic medical device. This invention can detect AMR in in-vitro and biofluid samples with over 90% accuracy in just 15 minutes, a huge reduction from the common wait time of over 72 hours.
Back to listing